Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Presenters Stand by Posters 4:00 p.m.–5:30 p.m.<br />
P2.200 Transcranial Direct Current<br />
Stimulation and Transcutaneous Occipital<br />
Nerve Stimulation in Chronic Migraine:<br />
A Pilot-Comparison of Therapeutic and<br />
Electrophysiological Effects —Jean<br />
Schoenen, Kevin D'Ostilio, Anna Cosseddu,<br />
Romain Nonis, Simona Sava, Delphine Magis<br />
P2.201 IV Dihydroergotamine for<br />
Treatment of Status Migrainosus in<br />
Children - Efficacy and Tolerability —<br />
Shannon Liang, Soe Mar<br />
P2.202 Non-Invasive Vagus Nerve<br />
Stimulation with the GammaCore<br />
in Healthy Subjects: Is There<br />
Electrophysiological Evidence for<br />
Activation of Vagal Afferents? —Jean<br />
Schoenen, Romain Nonis, Kevin D'Ostilio,<br />
Simona Sava, Delphine Magis<br />
P2.203 Treatment of Medication-<br />
Overuse Headache: A Systematic<br />
Review —Chia-Chun Chiang, Todd Schwedt,<br />
Shuu-Jiun Wang, David Dodick<br />
P2.204 Mindfulness Versus<br />
Pharmacological Preventative Treatment<br />
for Chronic Migraine (CM) with<br />
Medication Overuse (MO): Preliminary<br />
Findings —Licia Grazzi, Emanuela Sansone,<br />
Alberto Raggi, Matilde Leonardi, Domenico<br />
D'Amico, Frank Andrasik<br />
P2.205 Effect of CGRP Inhibition with<br />
TEV-48125 on Cardiovascular Parameters<br />
As a Function of Triptan Use Among<br />
Individuals with Chronic Migraine —<br />
Juliana VanderPluym, David Dodick, Marcelo<br />
Bigal<br />
P2.206 Prophylaxis and Acute<br />
Medication Treatment Patterns in<br />
Migraine Patients Initiating Migraine<br />
Prophylactic Therapy —Robert Lenz,<br />
Machaon Bonafede, Brett Maiese, J. Michael<br />
Woolley<br />
P2.207 Exploring the Effect of<br />
Childhood Abuse on Migraine, Depression<br />
and Anxiety Using Structural Equation<br />
Modeling —Gretchen Tietjen, Monita<br />
Karmakar, Jon Elhai, Aliaksander Amialchuk<br />
P2.208 Anodal Transcranial Direct<br />
Stimulation (tDCS) Targeting the Anterior<br />
Cingulate Gyrus for the Treatment of<br />
Chronic Cluster Headache: A Proof-of-<br />
Concept Trial —Delphine Magis, Kevin<br />
D'Ostilio, Anna Cosseddu, Romain Nonis,<br />
Simona Sava, Jean Schoenen<br />
P2.209 Real‐World Utilization and<br />
Safety of OnabotulinumtoxinA for Chronic<br />
Migraine Headache Prophylaxis: Interim<br />
Analysis from an Observational Study in<br />
the European Union —Manjit Matharu,<br />
Julio Pascual, Ingela Nilsson Remahl,<br />
Andreas Straube, Catherine Johannes, Dawn<br />
Odom, Lia Gutierrez, Elizabeth Andrews,<br />
Arlene Lum<br />
P2.210 A Randomized, Open-Label,<br />
Parallel Two-Arm Study Evaluating the<br />
Efficacy of H.P. Acthar Injection Gel in<br />
the Treatment of Adults with Treatment<br />
Resistant Chronic Migraine —Roger Cady,<br />
Laszlo Mechtler, Peter McAllister, John<br />
Rothrock, Heather Manley, Ryan Cady<br />
P2.211 Glyburide As Treatment Option<br />
in Decreasing Intracranial Pressure<br />
Associated with Idiopathic Intracranial<br />
Hypertension. —Roomana Ahad, Shawn<br />
Khosla, Iftekhar Ahmed<br />
P2.212 Importance of Documentation<br />
in the Primary Care Setting for Migraine<br />
Prevention —Andrew Buletko, Jessica<br />
Winslow, Mark Stillman, Cynthia Bamford<br />
P2.213 To PREEMPT or Not to<br />
PREEMPT: Is There an Ideal Botulinum<br />
Toxin Injection Strategy for Migraine<br />
Prevention? —Patrick Grogan, Maria<br />
Alvarez, Matthew Brock, Andrew Bursaw,<br />
Wendy Chao, Daniel Simmons, John Sladky,<br />
Jon Williams, Adam Willis<br />
P2.214 Treatment of Dopplerable<br />
Nummular Headache with Minimally<br />
Invasive Arterectomy Under Local<br />
Anaesthesia. Experience from the First 50<br />
Cases —Deborah Reed, Bahman Guyuron<br />
P2.215 Reduced Treatment-Emergent<br />
Nausea Using AVP-825 Vs. Sumatriptan<br />
Tablets: A Comparative Effectiveness<br />
Study —Kenneth Shulman, James McGinley,<br />
Dawn Buse, Stephen Silberstein, RJ Wirth,<br />
Joao Siffert, Richard Lipton<br />
P2.216 Atorvastatin Versus<br />
Propranolol in Prevention of Episodic<br />
Migraine. A Randomized Clinical Trial —<br />
Alejandro Marfil-Rivera, Hazael Flores<br />
P2.217 AVP-825 Reduces Nausea<br />
Faster Than Sumatriptan Tablets: A<br />
Comparative Effectiveness Study —James<br />
McGinley, Kenneth Shulman, RJ Wirth,<br />
Stephen Silberstein, Dawn Buse, Joao Siffert,<br />
Richard Lipton<br />
Aging and Dementia: Therapeutics<br />
P2.218 Daily Functioning Benefits<br />
of Adding Memantine to Stable<br />
Cholinesterase Treatment in Patients with<br />
Moderate to Severe Alzheimer’s Disease:<br />
A Post Hoc Pooled Factor Analysis —<br />
Gustavo Alva, Noel Ellison, Biplob Dass,<br />
Suzanne Hendrix<br />
P2.219 Caregiver Distress Related to<br />
Neuropsychiatric Symptoms is Reduced<br />
with Extended-Release Memantine -<br />
Cholinesterase Inhibitor Combination<br />
in Patients with Moderate to Severe<br />
Alzheimer’s Disease —Alireza Atri, Suzanne<br />
Hendrix, Noel Ellison, Victor Otcheretko, John<br />
Edwards<br />
P2.220 The Effect of Statins on Rate<br />
of Cognitive Decline in Mild Cognitive<br />
Impairment —Kyle Smith, Paul Kang,<br />
Marwan Sabbagh<br />
P2.221 Memantine-Induced Chorea<br />
and Dystonia —Letizia Borges, Borna<br />
Bonakdarpour<br />
P2.222 Deep Brain Stimulation<br />
of Frontal Lobe Networks to Treat<br />
Alzheimer’s Disease —Douglas Scharre,<br />
Emily Weichart, Dylan Nielson, Jun Zhang,<br />
Punit Agrawal, Per Sederberg, Michael<br />
Knopp, Ali Rezai<br />
P2.223 The Montefiore-Einstein<br />
Center for the Aging Brain: A New<br />
Model to Care for Those with Cognitive<br />
Impairment and Their Caregivers —Jason<br />
Cohen, Joe Verghese, Jessica Zwerling<br />
P2.224 The Nuedexta ALS Treatment<br />
Trial —Richard Smith, Erik Pioro, David<br />
Schoenfeld, Gary Pattee<br />
P2.225 PRISM II: Effectiveness of<br />
Dextromethorphan 20 Mg/Quinidine<br />
10 Mg (NUEDEXTA ® ) for Treatment<br />
of Pseudobulbar Affect Secondary to<br />
Dementia, Stroke, or Traumatic Brain<br />
Injury: Combined Results of a Multicenter<br />
Open-Label Study —Joao Siffert, Flora<br />
Hammond, David Alexander, Andrew Cutler,<br />
Stephen D'Amico, Rachelle Doody, William<br />
Sauve, Richard Zorowitz, Charles Davis, Paul<br />
Shin, Fred Ledon, Charles Yonan, Andrea<br />
Formella<br />
P2.226 Participant-Informant<br />
Relationship Affects Quality of Life<br />
Ratings in Incipient and Clinical<br />
Alzheimer’s Disease —Amy Lin, Jenny<br />
Brook, Joshua Grill, Edmond Teng<br />
P2.227 Optimizing Effect Sizes in Mild<br />
Alzheimer’s Disease Clinical Trials —<br />
Timothy Chang, Edmond Teng, Joshua Grill<br />
Alzheimer's Disease and Mild<br />
Cognitive Impairment<br />
P2.228 Amyloid-β and<br />
Hyperphosphorylated Tau Synergy Drives<br />
Clinical Progression in Individuals with<br />
Mild Cognitive Impairment —Tharick<br />
Pascoal, Andrea Benedet, Sulantha<br />
Mathotaarachchi, Jean-Paul Soucy, Tom<br />
Beaudry, Serge Gauthier, Pedro Rosa Neto<br />
P2.229 From Subjective Cognitive<br />
Impairment (PRE-MCI) to Alzheimer's<br />
Disease: A Two Year Follow UP Study of<br />
143 Subjects —Bernard Michel, Nathalie<br />
Sambuchi, Yonas Geda, Isabelle Muraccioli,<br />
Ronald Petersen<br />
P2.230 Behavioral Correlates of<br />
Cognitive Decline in Normal Aging and<br />
Prodromal Alzheimer’s Disease —Naira<br />
Goukasian, Triet Do, Jonathan Grotts, John<br />
Ringman, David Elashoff, Liana Apostolova<br />
P2.231 Quantitative Gait Parameters<br />
from MCI to Moderate Dementia: Results<br />
from the GOOD Initiative —Allali Gilles,<br />
Joe Verghese, Olivier Beauchet<br />
P2.232 Effect of Brain Amyloidosis<br />
on the Emergence of Neuropsychiatric<br />
Behaviors in MCI over Time —Liana<br />
Apostolova, Naira Goukasian, Triet Do,<br />
Jonathan Grotts, John Ringman, David<br />
Elashoff<br />
P2.233 Visual Ratings of Medial<br />
Temporal Lobe Atrophy Correlate with<br />
CSF Tau Indices in Early-Onset Alzheimer's<br />
Disease. —Elias Granadillo, Pongsatorn<br />
Paholpak, Mario Mendez, Edmond Teng<br />
P2.234 Cognitive and Functional<br />
Differences Between Delusions and<br />
Hallucinations in Alzheimer’s Disease —<br />
Winnie Qian, Corinne Fischer, Tom Schweizer,<br />
David Munoz<br />
P2.235 Prevalence of Amyloid<br />
Pathology in Primary Progressive Aphasia<br />
Variants: A Systematic Review and Meta-<br />
Analysis —David Bergeron, Robert Laforce,<br />
Rik Ossenkoppele<br />
P2.236 Characterization of<br />
Olfactory Identification Deficit in Aging<br />
Vs. Alzheimer’s Disease —Matthew<br />
Woodward, Muhammad Ubaid Hafeez, Umar<br />
Hayyat, Awais Ahmed, Jesper Hagemeier,<br />
Li Yan, Qianya Qi, Ralph Benedict, Robert<br />
Zivadinov, Kinga Szigeti<br />
P2.237 The Clinical Phenotype<br />
of Late-onset Autosomal Dominant<br />
Alzheimer Disease Due to a PSEN1<br />
Mutation Resembles Sporadic Alzheimer<br />
Disease: A Single-family Case-control<br />
Study —Gregory Day, Erik Musiek, Catherine<br />
Roe, Joanne Norton, Alison Goate, Carlos<br />
Cruchaga, John Morris<br />
Aging and Dementia: Other<br />
P2.238 Proposed Diagnostic Criteria<br />
for Adult-onset Leukoencephalopathy<br />
with Axonal Spheroids and Pigmented<br />
Glia —Takuya Konno, Kunihiro Yoshida,<br />
Toshiki Mizuno, Toshitaka Kawarai,<br />
Masayoshi Tada, Hiroaki Nozaki, Shu-Ichi<br />
Ikeda, Masatoyo Nishizawa, Osamu Onodera,<br />
Zbigniew Wszolek, Takeshi Ikeuchi<br />
P2.239 Spinocerebellar Ataxia<br />
Associated Psychosis and Tyrosine<br />
Hydroxylase Staining of the Midbrain —<br />
Katherine Turk, Margaret Flannagan, Suman<br />
Jayadev, Dirk Keene, Thomas Bird<br />
P2.240 Clinical Manifestations of<br />
Adult Onset Neuronal Intranuclear<br />
Inclusion Disease Cases Presenting<br />
Leukoencephalopathy —Jun Sone,<br />
Tomonori Inagaki, Keiko Mori, Kunihiko Araki,<br />
Michihito Masuda, Mari Yoshida, Yasushi<br />
Iwasaki, Fumiaki Tanaka, Masahisa Katsuno,<br />
Gen Sobue<br />
P2.241 WITHDRAWN<br />
P2.242 Use of Benzodiazepines<br />
and Risk of Dementia: A Retrospective<br />
Case-Control Study —Tsz-tai Chan, William<br />
Chun-yin Leung, Wesley Kin-yiu Wong, Wingming<br />
Chu, Ka-chun Leung, Yuey-zhun Ng,<br />
Gary Yuen-ming Kai, Victor Li, Yat-fung Shea,<br />
Chang Richard Shek-kwan, Shu-leong Ho<br />
P2.243 Disproportionately Enlarged<br />
Subarachnoid Space Hydrocephalus<br />
(DESH) Associated with Acoustic<br />
Schwannoma with Exquisite Response<br />
to Ventriculoperitoneal Shunting: A Case<br />
Report —Gabriel Pagani-Estevez, David<br />
Jones<br />
P2.244 Does Poor Gait Performance<br />
Predict Risk of Developing Dementia?<br />
Results From a Meta-analysis —Beauchet<br />
Olivier, Joe Verghese, Gilles Allali<br />
P2.245 Risk Factors for Blood-Brain<br />
Barrier Disruption in Patients with Chronic<br />
Cerebrovascular Disease Presenting with<br />
Acute Stroke —Nidhi Gupta, Marie Luby,<br />
Zurab Nadareishvili, Richard Benson, Amie<br />
Hsia, John Lynch, Richard Leigh<br />
Sun · April 17<br />
Fast and easy registration · AAN.com/view/AM16 51
Change language